CliffBio
small molecule

TUSSIONEX PENNKINETIC

CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX

Loss of exclusivity—loss of exclusivity
CompanyUCB →See this company's full patent-cliff portfolio

Drug detail

Brand nameTUSSIONEX PENNKINETIC
Active ingredientCHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX
StrengthEQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formSUSPENSION, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalDecember 1987
Marketing statusDISCN

More from UCB

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

TUSSIONEX PENNKINETIC patent cliff — loss of exclusivity — | CliffBio